AstraZeneca publishes the data from a study of more than 30,000 volunteers
The vaccine was also shown to be 100% effective at preventing severe disease, death and hospitalisation. So, that is arguably the more important statistic.

Continue Reading:…

Search Web: AstraZeneca US phase III vaccine trial shows 79% efficacy in preventing symptomatic cases

Recent Posts

Related Listening

December Reports

November Reports

October Reports

September Reports

Chinese (Simplified) ZH-CN English EN French FR German DE Spanish ES